Clinical consequences of mutations in sodium phosphate cotransporters.

Three families of sodium phosphate cotransporters have been described. Their specific roles in human health and disease have not been defined. Review of the literature reveals that the type II sodium phosphate cotransporters play a significant role in transepithelial transport in a number of tissues including kidney, intestine, salivary gland, mammary gland, and lung. The type I transporters seem to play a major role in renal urate handling and mutations in these proteins have been implicated in susceptibility to gout. The ubiquitously expressed type III transporters play a lesser role in phosphate homeostasis but contribute to cellular phosphate uptake, mineralization, and inflammation. The recognition of species differences in the expression, regulation, and function of these transport proteins suggests an urgent need to find ways to study them in humans.

Citation

Eleanor Lederer, Ken-ichi Miyamoto. Clinical consequences of mutations in sodium phosphate cotransporters. Clinical journal of the American Society of Nephrology : CJASN. 2012 Jul;7(7):1179-87

Mesh Tags

Substances

PMID: 22516291

search → result